NCT02651519View on ClinicalTrials.gov

Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Sleep Deprivation
Interventions
DRUG

0.25% ropivacaine hydrochloride

stellate-ganglion block with 0.25% ropivacaine hydrochloride

DRUG

saline

stellate-ganglion block with saline

Trial Locations (1)

110001

the First Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

China Medical University, China

OTHER

NCT02651519 - Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation | Biotech Hunter | Biotech Hunter